Research News

---

Topic: Diagnosis (view all topics)

Tags for topic Diagnosis:

• 1cm-1.9cm
• Ductal Carcinoma In Situ
• Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ)
• Early-stage: Stage IA
• Early-stage: Stage IB
• Early-stage: Stage IIA
• Early-stage: Stage IIB
• Early-stage: Stage IIIA
• Estrogen Receptor Negative Cancer
• Estrogen Receptor Positive Cancer
• HER2/neu Negative Cancer
• HER2/neu Positive Cancer
• HER2 Overexpressing
• Invasive or Infiltrating Ductal Carcinoma
• Invasive or Infiltrating Lobular Carcinoma
• Less than 1cm
• Locally Advanced-stage: Stage IIIB
• Locally Advanced-stage: Stage IIIC
• Luminal A
• Luminal B
• Metastatic
• Metastatic/Advanced-stage: Stage IV
• Non-Metastatic
• Progesterone Receptor Negative Cancer
• Progesterone Receptor Positive Cancer
• Regional
• Triple Negative

View articles by month and year

• FDA Advisory Panel Approves MarginProbe System

  Published on June 26, 2012 at 12:00 am

  • Tags: Ductal Carcinoma In Situ, Invasive or Infiltrating Ductal Carcinoma, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Lumpectomy, Non-Metastatic, and Invasive or Infiltrating Lobular Carcinoma

  An FDA expert panel voted to approve the MarginProbe system - a device that helps surgeons decide if all the cancer tissue has been removed during lumpectomy.

• Breast Cancer’s Hormone Receptor and HER2 Status Can Change After Diagnosis

  Published on June 20, 2012 at 12:00 am

  • Tags: Locally Advanced-stage: Stage IIIB, Locally Advanced-stage: Stage IIIC, Metastatic/Advanced-stage: Stage IV, Progesterone Receptor Negative Cancer, Progesterone Receptor Positive Cancer, Estrogen Receptor Negative Cancer, Estrogen Receptor Positive Cancer, HER2/neu Positive Cancer, Metastatic, Non-Metastatic, Regional, Biopsy, FISH Test, IHC Test, Inform HER2 Dual ISH Test, SPoT-Light HER2 CISH, HER2/neu Negative Cancer, Luminal A, Luminal B, Triple Negative, and HER2 Overexpressing

  The characteristics of a breast cancer -- including hormone receptor status and HER2 status -- can change over time. These changes may happen because the cancer cells change themselves or because treat...

• Circulating Tumor Cells Linked to Worse Prognosis in Early-Stage Disease

  Published on June 19, 2012 at 12:00 am

  • Tags: Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Non-Metastatic, and Blood Marker Tests

  A study has found that circulating tumor cells in the bloodstream are linked to worse prognosis in people diagnosed with early-stage breast cancer.

• Women Older Than 65 Have Worse Outcomes After Breast Cancer Diagnosis

  Published on February 7, 2012 at 12:00 am

  • Tags: Progesterone Receptor Positive Cancer, Estrogen Receptor Positive Cancer, Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, and Early-stage: Stage IIIA

  A large study has found that women older than 65 diagnosed with early-stage, hormone-receptor-positive breast cancer had worse outcomes than younger women with similar diagnoses.

• Breast Cancer Cells in Sentinel Lymph Node Don’t Affect Survival

  Published on July 26, 2011 at 12:00 am

  • Tags: Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, and Early-stage: Stage IIIA

  Research strongly suggests that occult metastases in the sentinel lymph node of women diagnosed with early-stage breast cancer don't affect survival.

• High C-Reactive Protein Levels May Influence Prognosis

  Published on June 3, 2011 at 12:00 am

  • Tags: Invasive or Infiltrating Ductal Carcinoma, Invasive or Infiltrating Lobular Carcinoma, Non-Metastatic, Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Locally Advanced-stage: Stage IIIB, and Locally Advanced-stage: Stage IIIC

  Research suggests that C-reactive protein levels may be linked to prognosis after a breast cancer diagnosis.

• Older Women Diagnosed with DCIS or Early-Stage Disease Have Excellent Prognosis

  Published on March 16, 2011 at 12:00 am

  • Tags: Non-Metastatic, 1cm-1.9cm, Less than 1cm, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Ductal Carcinoma In Situ, Invasive or Infiltrating Ductal Carcinoma, and Invasive or Infiltrating Lobular Carcinoma

  A large study found that women older than 67 diagnosed with either DCIS or stage I breast cancer were just as likely to be alive 10 years after diagnosis as women not diagnosed with breast cancer.

• Single Cancer Cells in Sentinel Node Don’t Affect Prognosis

  Published on January 19, 2011 at 12:00 am

  • Tags: Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, and Early-stage: Stage IIIA

  A large study suggests that women diagnosed with early-stage breast cancer who have occult metastases in a clinically negative sentinel node do almost as well as women without occult metastases.

• Circulating Tumor Cells Linked to Worse Prognosis

  Published on December 15, 2010 at 12:00 am

  • Tags: Metastatic, Non-Metastatic, Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Locally Advanced-stage: Stage IIIB, Locally Advanced-stage: Stage IIIC, Metastatic/Advanced-stage: Stage IV, and Blood Marker Tests

  New studies suggest that even one circulating tumor cell in a blood sample from a woman diagnosed with breast cancer is linked to a worse prognosis.

• Breast Cancer Survival Triples in Last 60 Years

  Published on September 30, 2010 at 12:00 am

  • Tags: Metastatic, Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Locally Advanced-stage: Stage IIIB, Locally Advanced-stage: Stage IIIC, and Metastatic/Advanced-stage: Stage IV

  During the past 60 years, the average number of women who survived for 10 years after being diagnosed with breast cancer and treated at the University of Texas MD Anderson Cancer Center tripled.